HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention

Research output: Contribution to journal › Comment/debate › Research

Standard

HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention. / Bruhn, Christian Anders Wathne; Gilbert, Tom.

In: The Lancet Infectious Diseases, Vol. 11, No. 4, 04.2011, p. 260-261.

Research output: Contribution to journal › Comment/debate › Research

Harvard

Bruhn, CAW & Gilbert, T 2011, 'HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention', The Lancet Infectious Diseases, vol. 11, no. 4, pp. 260-261. https://doi.org/10.1016/S1473-3099(11)70037-8

APA

Bruhn, C. A. W., & Gilbert, T. (2011). HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention. The Lancet Infectious Diseases, 11(4), 260-261. https://doi.org/10.1016/S1473-3099(11)70037-8

Vancouver

Bruhn CAW, Gilbert T. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention. The Lancet Infectious Diseases. 2011 Apr;11(4):260-261. https://doi.org/10.1016/S1473-3099(11)70037-8

Author

Bruhn, Christian Anders Wathne ; Gilbert, Tom. / HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention. In: The Lancet Infectious Diseases. 2011 ; Vol. 11, No. 4. pp. 260-261.

Bibtex

@article{dbc739de76a3469c95ac558aade84ec9,
title = "HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention",
keywords = "Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Disease Transmission, Infectious, HIV Infections, HIV-1, HIV-2, Humans",
author = "Bruhn, {Christian Anders Wathne} and Tom Gilbert",
year = "2011",
month = apr,
doi = "10.1016/S1473-3099(11)70037-8",
language = "English",
volume = "11",
pages = "260--261",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "TheLancet Publishing Group",
number = "4",

}

RIS

TY - JOUR

T1 - HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention

AU - Bruhn, Christian Anders Wathne

AU - Gilbert, Tom

PY - 2011/4

Y1 - 2011/4

KW - Anti-HIV Agents

KW - Antiretroviral Therapy, Highly Active

KW - Disease Transmission, Infectious

KW - HIV Infections

KW - HIV-1

KW - HIV-2

KW - Humans

U2 - 10.1016/S1473-3099(11)70037-8

DO - 10.1016/S1473-3099(11)70037-8

M3 - Comment/debate

C2 - 21453865

VL - 11

SP - 260

EP - 261

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 4

ER -

ID: 34347661